The Effect of Infant Formulas With 4 or 8 g/L GOS/FOS on Growth, Gastrointestinal Symptoms, and Behavioral Patterns:...

Area of Science:

• Pediatrics
• Nutrition Science
• Gastroenterology

Background:

• Limited research exists on the clinical benefits of prebiotic-supplemented infant formula.
• Prebiotics like galacto-oligosaccharides/fructo-oligosaccharides (GOS/FOS) are added to infant formulas to mimic breast milk composition.
• Understanding optimal prebiotic dosage is crucial for infant development and well-being.

Purpose of the Study:

• To evaluate the clinical benefits of two different doses of GOS/FOS in infant formula.
• To compare the growth and gastrointestinal symptoms of infants fed GOS/FOS-supplemented formula with exclusively breastfed infants.
• To determine if a higher dose of GOS/FOS offers additional benefits.

Main Methods:

• A 30-day study involving healthy infants on artificial feeding.
• Infants were divided into two groups receiving formula with either 4 g/L (IF4) or 8 g/L (IF8) of GOS/FOS (9:1 ratio).
• A control group of exclusively breastfed (EBF) infants was included for comparison.

Main Results:

• Both IF4 and IF8 formulas supported adequate infant weight gain.
• The IF4 group exhibited growth patterns more similar to the EBF group.
• No significant additional benefit in gastrointestinal symptoms was observed with the higher 8 g/L GOS/FOS dose compared to the 4 g/L dose.

Conclusions:

• Infant formula supplemented with 4 g/L GOS/FOS supports growth comparable to breastfed infants.
• Increasing GOS/FOS dosage beyond 4 g/L in infant formula does not appear to provide additional benefits for gastrointestinal symptoms.
• The findings suggest an optimal GOS/FOS dosage for infant formula, balancing growth and digestive comfort.